129 related articles for article (PubMed ID: 22283510)
1. Pharmacokinetics and urine metabolite identification of dehydroevodiamine in the rat.
Lin LC; Li SH; Wu YT; Kuo KL; Tsai TH
J Agric Food Chem; 2012 Feb; 60(7):1595-604. PubMed ID: 22283510
[TBL] [Abstract][Full Text] [Related]
2. Characterization of new metabolites from in vivo biotransformation of norisoboldine by liquid chromatography/mass spectrometry and NMR spectroscopy.
Chen JZ; Chou GX; Wang CH; Yang L; Bligh SW; Wang ZT
J Pharm Biomed Anal; 2010 Sep; 52(5):687-93. PubMed ID: 20223612
[TBL] [Abstract][Full Text] [Related]
3. Elimination of rutaecarpine and its metabolites in rat feces and urine measured by liquid chromatography.
Jan WC; Lin LC; Don MJ; Chen CF; Tsai TH
Biomed Chromatogr; 2006 Nov; 20(11):1163-71. PubMed ID: 16799925
[TBL] [Abstract][Full Text] [Related]
4. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, metabolism, and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in rats and rhesus monkeys.
Tan EY; Hartmann G; Chen Q; Pereira A; Bradley S; Doss G; Zhang AS; Ho JZ; Braun MP; Dean DC; Tang W; Kumar S
Drug Metab Dispos; 2010 Mar; 38(3):459-73. PubMed ID: 20016052
[TBL] [Abstract][Full Text] [Related]
6. Identification of ginkgolic acid (15:1) metabolites in rats following oral administration by high-performance liquid chromatography coupled to tandem mass spectrometry.
Xia H; Liu Z; Hu H; Zhou H; Zeng S
Xenobiotica; 2013 May; 43(5):454-60. PubMed ID: 23205533
[TBL] [Abstract][Full Text] [Related]
7. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D
Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
[TBL] [Abstract][Full Text] [Related]
8. Characterization of metabolites of tanshinone IIA in rats by liquid chromatography/tandem mass spectrometry.
Li P; Wang GJ; Li J; Hao HP; Zheng CN
J Mass Spectrom; 2006 May; 41(5):670-84. PubMed ID: 16598708
[TBL] [Abstract][Full Text] [Related]
9. Relative determination of dehydroevodiamine in rat plasma by LC-MS and study on its pharmacokinetics.
Yan R; Wang Y; Shen W; Zhao X; Zhang X
J Chromatogr Sci; 2012 Aug; 50(7):582-5. PubMed ID: 22525878
[TBL] [Abstract][Full Text] [Related]
10. Metabolism, pharmacokinetics, and excretion of the substance P receptor antagonist CP-122,721 in humans: structural characterization of the novel major circulating metabolite 5-trifluoromethoxy salicylic acid by high-performance liquid chromatography-tandem mass spectrometry and NMR spectroscopy.
Colizza K; Awad M; Kamel A
Drug Metab Dispos; 2007 Jun; 35(6):884-97. PubMed ID: 17360832
[TBL] [Abstract][Full Text] [Related]
11. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
Kurebayashi H; Betsui H; Ohno Y
Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
[TBL] [Abstract][Full Text] [Related]
12. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
[TBL] [Abstract][Full Text] [Related]
13. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
Prakash C; Soliman V
Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
[TBL] [Abstract][Full Text] [Related]
14. Biotransformation and pharmacokinetics of the antiplasmodial naphthylisoquinoline alkaloid dioncophylline A.
Sieber M; Dekant W; Faber JH; Bringmann G
Xenobiotica; 2006 Sep; 36(9):750-62. PubMed ID: 16971341
[TBL] [Abstract][Full Text] [Related]
15. Identification of circulatory and excretory metabolites of meisoindigo in rat plasma, urine and feces by high-performance liquid chromatography coupled with positive electrospray ionization tandem mass spectrometry.
Huang M; Lee YS; Ho PC
Rapid Commun Mass Spectrom; 2010 Mar; 24(6):729-41. PubMed ID: 20169560
[TBL] [Abstract][Full Text] [Related]
16. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.
Denissen JF; Grabowski BA; Johnson MK; Buko AM; Kempf DJ; Thomas SB; Surber BW
Drug Metab Dispos; 1997 Apr; 25(4):489-501. PubMed ID: 9107549
[TBL] [Abstract][Full Text] [Related]
17. Toxicokinetics and biotransformation of 3-(4-methylbenzylidene)camphor in rats after oral administration.
Völkel W; Colnot T; Schauer UM; Broschard TH; Dekant W
Toxicol Appl Pharmacol; 2006 Oct; 216(2):331-8. PubMed ID: 16806338
[TBL] [Abstract][Full Text] [Related]
18. Disposition and metabolism of the hypoglycemic agent pioglitazone in rats.
Krieter PA; Colletti AE; Doss GA; Miller RR
Drug Metab Dispos; 1994; 22(4):625-30. PubMed ID: 7956739
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the metabolism of sibiricaxanthone F and its aglycone in vitro by high performance liquid chromatography coupled with Q-trap mass spectrometry.
Song Y; Yang X; Jiang Y; Tu P
J Pharm Biomed Anal; 2012 Nov; 70():700-7. PubMed ID: 22819207
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and excretion of kakkalide and its metabolites in rat urine, bile, and feces as determined by HPLC/UV and LC/MS/MS.
Wang H; Bai X; Sun J; Kano Y; Makino T; Yuan D
Planta Med; 2013 Nov; 79(16):1552-7. PubMed ID: 24108437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
